Your browser doesn't support javascript.
loading
Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
Ni, Tengyang; Wang, Haibo; Li, Dan; Tao, Li; Lv, Mengying; Jin, Feng; Wang, Weimin; Feng, Jun; Qian, Yayun; Sunagawa, Masataka; Liu, Yanqing.
Affiliation
  • Ni T; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Wang H; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Li D; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Tao L; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
  • Lv M; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
  • Jin F; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Wang W; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Feng J; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Qian Y; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Sunagawa M; Department of Physiology, School of Medicine, Showa University, Tokyo 142, Japan.
  • Liu Y; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China. Electronic address: liuyq@yzu.edu.cn.
Biomed Pharmacother ; 123: 109823, 2020 03.
Article in En | MEDLINE | ID: mdl-31959384
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2020 Document type: Article Affiliation country: China Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2020 Document type: Article Affiliation country: China Country of publication: France